📰 Initial Data News
Page 2 - Initial Data News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Initial Data. Real-time updates on events, politics, business and more.
December 13, 2022
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
November 3, 2022
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
November 3, 2022
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
October 12, 2022
Alani Nu Pre-Workout supplements claim to increase physical endurance, improve energy and focus, and boost your mood 2023. Is this true?
September 14, 2022
Sosiaalisessa mediassa levisi 13.
September 14, 2022
Sosiaalisessa mediassa levisi 13.
August 9, 2022
Initial Data from Friedreich Ataxia Phase 1 Trial of DT-216 Expected in the Fourth Quarter of 2022 Strong Financial Position with $359.4 Million in Cash and Securities to Support Multi-Year... | August 8, 2022
August 3, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 4, 2022
Initial Data from REDWOOD-HCM OLE, the Open Label Extension Study of Aficamten, to be Presented at Heart Failure 2022 on May 23, 2022 Continued Launch...
May 4, 2022
G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights - read this article along with other careers information, tips and advice on BioSpace